Competition & Peer Data API & CSV Delivery

4front Ventures's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of 4front Ventures (FFNTF) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2024
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-25.52 %
Q3 2024
Net Margin
-37.37 %
Q3 2024

Key Findings: 4front Ventures vs Its Competitors

  • TTM: Trailing 12-month revenue of 76M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-9.4% annualized vs trailing 12 months).
  • Peer revenue share: 4front Ventures accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

FFNTF Sales vs. its Competitors, Q3 2024

4front Ventures generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/FFNTF/competitors
https://api.csimarket.com/api/v1/companies/FFNTF/relationships
https://api.csimarket.com/api/v1/companies/FFNTF/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Legal Cannabis industry grew revenue 35.0% year over year, combined, vs -25.5% for 4front Ventures. 4front Ventures's share of combined industry revenue moved from 0.96% to 0.53%, a loss of 0.43 percentage points.

4front Ventures's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
4front Ventures Corp No No No No
High-Confidence Competitors (2) 50% 50% 50% -
Similar Growth & Profitability (8) 12.50 % (1 of 8) 25.00 % (2 of 8) 12.50 % (1 of 8) 66.70 % (4 of 6)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2024

100%market share
  • 4front Ventures100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of 4front Ventures and its 0 tracked competitors.

See 4front Ventures's full market share breakdown »

FFNTF Stock Performance relative to its Competitors

FFNTF Competitors (weighted) Percent change over the selected range

FFNTF Stock Performance relative to High-Confidence Competitors

FFNTF High-Confidence Competitors (equal-weighted, 6) Percent change over the selected range

FFNTF Stock Performance relative to Similar Growth & Profitability Competitors

FFNTF Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

4front Ventures's Comment on Competition and Industry Peers

The company operates in the highly competitive cannabis industry, where competition is based on quality, price, brand recognition, and distribution strength. It competes with thousands of cannabis producers, ranging from small operations to multi-billion-dollar multi-state operators. Principal multi-state operator competitors include Curaleaf Holdings, Inc., Green Thumb Industries Inc., Cresco Labs Inc., Ascend Wellness Holdings, Inc., and MariMed, Inc.

4front Ventures's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Harvest Health & Recreation, Inc. Named by the company 85% 2022 to 2026 3
Curaleaf Holdings, Inc. Named by the company 85% 2022 to 2026 3
Ascend Wellness Holdings, Inc. Named by the company 85% 2022 to 2026 3
iAnthus Capital Holdings, Inc. Named by the company 85% 2022 to 2026 3
Green Thumb Industries Inc. Named by the company 85% 2022 to 2026 3
Cresco Labs Inc. Named by the company 85% 2022 to 2026 3
MariMed, Inc. Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for 4front Ventures's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

4front Ventures's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
4front Ventures Corp Massachusetts 46.01 % Illinois 42.35 % Corporate 11.64 %

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).